Wael Fayad and Stephen Hallenbeck Appointed Partners at Hildred Capital Management
Hildred Capital Management (“Hildred”), a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies, today announced that Wael Fayad and Stephen Hallenbeck have both been appointed Partners at the firm.
- Hildred Capital Management (“Hildred”), a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies, today announced that Wael Fayad and Stephen Hallenbeck have both been appointed Partners at the firm.
- On behalf of Hildred, Co-Founders and Managing Partners Andrew Goldman and David Solomon stated:
"We are pleased to announce the promotions of Wael and Stephen, which reflect the vital impact and contributions that each of them has had on the growth of our firm. - Wael is an integral part of our team and has been intimately involved in strategically managing several of our portfolio companies, including Carlin Consumer Health, Hyland’s Naturals, and Crown Laboratories.
- He then worked at Forest Laboratories Inc. for 14 years and served as Corporate Vice President of Business Development.